Crispr Therapeutics shares owned by ARK Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by ARK Investment Management
from 13F filings
Historical chart of ARK Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by ARK Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by ARK Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $634M | 9.8M | 64.81 |
| 2025-06-30 | $495M | 10M | 48.64 |
| 2025-03-31 | $346M | 10M | 34.03 |
| 2024-12-31 | $353M | 9.0M | 39.36 |
| 2024-09-30 | $352M | 7.5M | 46.98 |
| 2024-06-30 | $420M | 7.8M | 54.01 |
| 2024-03-31 | $556M | 8.2M | 68.16 |
| 2023-12-31 | $534M | 8.5M | 62.60 |
| 2023-09-30 | $325M | 7.2M | 45.39 |
| 2023-06-30 | $412M | 7.3M | 56.14 |
| 2023-03-31 | $361M | 8.0M | 45.23 |
| 2022-12-31 | $318M | 7.8M | 40.65 |
| 2022-09-30 | $538M | 8.2M | 65.35 |
| 2022-06-30 | $565M | 9.7M | 58.05 |
| 2022-03-31 | $590M | 9.4M | 62.77 |
| 2021-12-31 | $689M | 9.1M | 75.78 |
| 2021-09-30 | $849M | 7.6M | 111.93 |
| 2021-06-30 | $1.3B | 7.8M | 161.89 |
| 2021-03-31 | $1.0B | 8.3M | 121.85 |
| 2020-12-31 | $1.6B | 10M | 153.11 |
| 2020-09-30 | $707M | 8.5M | 83.64 |
| 2020-06-30 | $477M | 6.5M | 73.49 |
| 2020-03-31 | $182M | 4.3M | 42.41 |
| 2019-12-31 | $180M | 3.0M | 60.91 |
| 2019-09-30 | $114M | 2.8M | 40.99 |
| 2019-06-30 | $128M | 2.7M | 47.10 |
| 2019-03-31 | $72M | 2.0M | 35.72 |
| 2018-12-31 | $38M | 1.3M | 28.57 |
| 2018-09-30 | $65M | 1.5M | 44.35 |
| 2018-06-30 | $27M | 467k | 58.76 |
| 2018-03-31 | $3.3M | 73k | 45.72 |
| 2017-12-31 | $737k | 31k | 23.48 |
| 2017-06-30 | $206k | 13k | 15.98 |